SlideShare a Scribd company logo
1
Neonatal Respiratory
Distress Syndrome, NRDS
(hyaline membrane disease, HMD)
2
Aims
 To master the clinical manifestation and
treatment principles
 To understand the cause and
Pathogenesis
 To understand the differential diagnosis
3
 Most common respiratory illness in NICU
 Primarily characterized by respiratory
distress
 Occur virtually exclusively in premature
neonate
 The shorter the gestational age and the
lower birth weight, the higher incidence,
the less likely survival.
High Spot
4
Most infants with the disease die
from a complication , such as
 intracranial hemorrhage
 infection
 air leak syndromes
 bronchopulmonary dysplasia
5
Etiology
 The main cause:
Pulmonary Surfactant (PS) Deficiency
6
 lowers the surface
tension of the
alveolar membrane.
 maintains patent
distal lung units at
low volumes during
expiration.
 Increase in lung
compliance.
The Actions of pulmonary Surfactant:
normal abnormal
end expiratory
7
Phosphatidylcholine (75%)
Phosphatidylglycerol (9%)
Apoproteins (13%)
Cholesterol
Pulmonary Surfactant
Constituent:
8
Pulmonary Surfactant
 PS is produced by alveolar type Ⅱcells
 At 24thweeks : begin to increase progressively
with advancing gestational age
 At 34th-36thweeks : large increase
9
The other factors
 Genetic factors: white race, history of
RDS in sibling, male sex.
severe RDS---can not be cured----die
 Hormones factors
(adrenergic and steroid hormones can
promote PS production and release )
elective cesarean section
10
 Without surfactant the alveoli collapse at
the end of expiration.
 Pulmonary hypertension
So, absence of surfactant cause hypoxia,
acidosis, blood vessel contract , capillary vessel
and alveolus osmosis increase, blood plasma
leak, transparent membrane come into being,
dyspnea, RDS
Pathogenesis
11
absence of surfactant hypoxia,
acidosis blood vessel contract
capillary vessel and alveolus osmosis
increase blood plasma leak
transparent membrane come into
being dyspnea.
So, absence of surfactant cause NRDS
12
 This in turn leads to respiratory
failure .
 In older infants surfactant
deficiency can arise when they
develop asphyxia 、 shock and
acidosis.
13
Pathology
 Generalized capillary leak and mucosal
necrosis leads to the small air filled
terminal airways.
 The respiratory bronchioles and alveolar
ducts, being surrounded by collapsed
alveoli filled with debris in a near
uniform distribution, and this leads to the
classic "ground glass" appearance on the
chest X-ray.
14
 The NRDS affects the lung which is
not mature at delivery.
 Signs of respiratory distress appear
in 2-6hr after birth.
 Many of the patients appear signs
within minutes of birth---shallow
respirations are more than 60/min .
Sign
15
 Infants have physical findings of
prematurity and present with
inspiratory supraclavicular ,
suprasternal and intercostals
retractions (three depression signs)
16
Clinical Manifestations
 Tachypnea ( increasingly )
supraclavicular
 Three depression suprasternal
signs
intercostals
 Expiratory grunting (groan)
 Cyanosis
 Nasal flaring
 Apneic episode
17
 progressing to a paradoxical seesaw
respiratory pattern in which the chest
sinks is on inspiration as the abdomen
balloons upward.
 Expiratory grunting, tachypnea, flaring
of the Nasal ala and requirement for
oxygen completes the clinical picture.
18
 As the infant’s energy reserves
become depleted, there may be
cessation of grunting.
19
 Hypoperfusion and poor capillary
filling may progress to hypotension
and shock unless intervention is
aggressive.
 In most cases, the signs and
symptoms may reach a peak within
3 days, followed by gradual
resolution over the next 5-7days.
20
 If the condition is inadequately
treated, blood pressure and body
temperature may fall.
 Death is rare on the first day, usually
occurs between days 2-7.
21
Complications
Complications of NRDS include
 infections (Sepsis)
 intracranial hemorrhage
 hyperbilirubinemia
22
Complications
 PDA
 Cardiac failure caused by a left-to-
right shunt through a patent ductus
arteriosus.
 Pneumothorax
 Chronic lung disease
23
Laboratory examination
1. Chest X-ray :
 changes usually appear shortly after
birth, but can be delayed for 12-24 hours.
The typical pattern at 6-12 hour.
 Ground glass appearance
 Air bronchograms
 White lung
24
Ground glass
25
Air bronchograms
26
White lung
27
 2. Gastric aspirate shake (Foam test):
Put 1ml gastric fluid and 1ml 95%
alcohol into a tube, shake 15 seconds
and keep still 15 minutes. If there is
foam around the wall of the tube, it is
positive. If not--negative.
28
 3. Test of PS:
Test amniotic fluid or tracheal fluid
for lecithin / sphingomyelin. L/S ≥2
denotes mature lung, L/S <1.5
denotes immature lung, between 1.5
and 2 denotes doubtful.
29
Acid base In NRDS
 pH
 PaCO2
 PaO2
 HCO3
-
 BE deficit
30
Diagnosis Process
1. History of premature
2. Clinical signs: Respiratory distress
3. X-ray : ground glass , Air
bronchograms
4. Gastric aspirate shake: Negative
5. Blood gas and acid-base values:
hypoxemia, hypercarbia and metabolic acidosis.
31
Differential Diagnosis of NRDS
1. GBS Infection pneumonia (Congenital pneumonia)
– Pneumonia causes by group B streptococcus (GBS).
Same signs of NRDS .
– The chest X-ray may be identical in both diseases.
The onset and the manifestations of respiratory
distress are often indistinguishable. Apnea in the
first few hours is more likely in GBS pneumonia.
– Bacterial culture
32
 Sepsis risk factors
– Maternal fever, cough
– Leukocytosis or leukopenia with
neutropenia strongly suggests the presence
of GBS infection.
– Sometimes GBS can be found in gastric
fluid.
33
2.Wet Lung
Usually lung fluid is cleared from the interstitial
space veins and lymphatics within 30 minutes
after birth.
Chest X-ray, usually has non-homogeneous
densities, may have interlobar effusion .
Clinical manifestations appear within several
hours after birth, but are milder than HMD.
34
Lung
fluid
air
First breath Second btreath 30min later
Lung fluid clear away
35
3.Meconium aspiration
 Common in full term infant or postterm infant
 Gasping cause is the aspiration
 Chemical diffuse pneumonitis
 Chest X-ray, patchy areas of decreased aeration
alternating with hyperventilation areas
 Treatment mainly supportive
36
Treatment Principle
 Surfactant …1990s
– Prevention (100mg/Kg)
– Rescue (200mg/Kg)
 Supportive
– Thermal
– Fluid and nutrition
– oxygen
 Mechanical ventilation
37
Therapy
1. General Comments
Therapy of hyaline membrane
disease (HMD) is complex.
Major responsibility befalls nurses.
Blood gases and pH should be check
according to necessary.
38
2.Surfactant Replacement
Endotracheal instillation of surfactant
replacement has dramatically improved
survival and reduced the incidence of
pulmonary air leaks.
100-200mg/kg drop in bronchi of both sides 2-
4 times.
Curosurf (irrigating solution of piggy lung)
Calsurf (irrigating solution of calf lung)
39
3. Other treatment
1) Respiratory Support
a. Nasal oxygen catheter (Flow: 0.5-1L/min)
Warm humidified oxygen should be provided
to maintain :
 PaO2 between 50 and 70 mmHg
 pH above 7.25
 PaCO2 between 45 and 50 mmHg.
40
 b. CPAP(Continuos Positive Airway
Pressure ):
PEEP (positive end-expiratory pressure) :
4-10cm H2O.
rhinobyon
Air and
o2mixer
4-10cmH2O
41
42
b. Mechanical ventilation : After CPAP (FiO2>60%),
if PaO2<6.7Kpa (50mmHg) or PaCO2>7.9Kpa
(60mmHg), ventilation should be used.
 SIPPV (Synchronized Intermittent Positive
Pressure Ventilation )
 SIMV (Synchronized Intermittent Mandatory
Ventilation )
43
2) Acid-base Balance
– A metabolic acidosis can be prevented
by adding a small quantity of sodium
bicarbonate.
– Formula
 5% NaHCO3 3- 5ml/kg, one time, IV
 5%NaHCO3 (mmol) = -BE ×0.3× kg
 5%NaHCO3 (ml) = -BE × 0.5 × kg
44
3) Keep Body Temperature
Maintenance of a neutral thermal
environment ( skin temperature
between 36.2-36.8℃) is of crucial
importance.
45
4) Nutrition
– During the first 24 to 48 hours, caloric
needs are partially met by continuous
intravenous infusion. volumes are 60-80
ml/kg/d.
– Ensure that the blood sugar is maintained
within a normal range(>2.5mmol/L).
– If bowel sounds are audible and meconium
has been passed, the milk should be fed.
46
5) Antibiotic can be used to prevent
infection of lung.
47
Preventive measures
1. Prevent Premature Deliveries.
Including :
 avoidance of unnecessary or pool timed
cesarean section
 appropriate management of high-risk
pregnancy and labor
 prediction possible in uterus acceleration
of pulmonary immaturity.
48
2. Administration of Corticosteroids
There is good evidence that the
administration of corticosteroids to
mothers who are in premature labor to
diminish the incidence of NRDS. Their
effect is maximal at gestational ages
between 28 and 32 weeks. Steroids should
be administered between 24 hours and
7days before delivery.
49
Thanks !

More Related Content

Similar to 6--NEONATOLOGY NRDS{6}.ppt

Respiratory Distress(RDS)
Respiratory Distress(RDS)Respiratory Distress(RDS)
Respiratory Distress(RDS)
Tek Khadka
 
NEONATAL RESPIRATORY DISTRESS SYNDROME
NEONATAL RESPIRATORY DISTRESS SYNDROMENEONATAL RESPIRATORY DISTRESS SYNDROME
NEONATAL RESPIRATORY DISTRESS SYNDROME
SUDESHNA BANERJEE
 
Respiratory distress syndrome
Respiratory distress syndromeRespiratory distress syndrome
Respiratory distress syndrome
NiveditaMishra17
 
Respiratory distress syndrome
Respiratory distress syndromeRespiratory distress syndrome
Respiratory distress syndrome
Binand Moirangthem
 
RDS-.pptx
RDS-.pptxRDS-.pptx
RDS-.pptx
asst professer
 
Respiratory distress of the newborn
Respiratory distress of the newbornRespiratory distress of the newborn
Respiratory distress of the newborn
snich
 
Respiratory distress in newborn
Respiratory distress in newbornRespiratory distress in newborn
Respiratory distress in newborn
Kyi San Thi
 
Respiratory distress syndrome^.^.pptx
Respiratory distress syndrome^.^.pptxRespiratory distress syndrome^.^.pptx
Respiratory distress syndrome^.^.pptx
EADavidKoli
 
Dr. Radhey Shyam (presentation)
Dr. Radhey Shyam (presentation)Dr. Radhey Shyam (presentation)
Dr. Radhey Shyam (presentation)rsd8106
 
Continuous Positive Airway Pressure.pptx
Continuous Positive Airway Pressure.pptxContinuous Positive Airway Pressure.pptx
Continuous Positive Airway Pressure.pptx
DrMSajidNoor
 
Pediatric ARDS
Pediatric ARDSPediatric ARDS
Pediatric ARDS
Abhijeet Deshmukh
 
Respiratory Distress Syndrome by DR FAITHFUL DANIEL.pptx
Respiratory Distress Syndrome  by DR FAITHFUL DANIEL.pptxRespiratory Distress Syndrome  by DR FAITHFUL DANIEL.pptx
Respiratory Distress Syndrome by DR FAITHFUL DANIEL.pptx
DanielFaithful
 
Bronchectasis DISEASE MFM faculty 2017 .pdf
Bronchectasis DISEASE MFM faculty 2017 .pdfBronchectasis DISEASE MFM faculty 2017 .pdf
Bronchectasis DISEASE MFM faculty 2017 .pdf
ahmednasser648712
 
Paediatric respiratory physiology
Paediatric  respiratory physiologyPaediatric  respiratory physiology
Paediatric respiratory physiology
Priyanka Karnik
 
Noisy breathing
Noisy breathingNoisy breathing
Noisy breathing
Hisham Alrabty
 

Similar to 6--NEONATOLOGY NRDS{6}.ppt (20)

Respiratory Distress(RDS)
Respiratory Distress(RDS)Respiratory Distress(RDS)
Respiratory Distress(RDS)
 
Dffy
DffyDffy
Dffy
 
Nrds
NrdsNrds
Nrds
 
Ppt bpd
Ppt bpdPpt bpd
Ppt bpd
 
Bronchiolitis
BronchiolitisBronchiolitis
Bronchiolitis
 
NEONATAL RESPIRATORY DISTRESS SYNDROME
NEONATAL RESPIRATORY DISTRESS SYNDROMENEONATAL RESPIRATORY DISTRESS SYNDROME
NEONATAL RESPIRATORY DISTRESS SYNDROME
 
Respiratory distress syndrome
Respiratory distress syndromeRespiratory distress syndrome
Respiratory distress syndrome
 
Respiratory distress syndrome
Respiratory distress syndromeRespiratory distress syndrome
Respiratory distress syndrome
 
RDS-.pptx
RDS-.pptxRDS-.pptx
RDS-.pptx
 
Respiratory distress of the newborn
Respiratory distress of the newbornRespiratory distress of the newborn
Respiratory distress of the newborn
 
Respiratory distress in newborn
Respiratory distress in newbornRespiratory distress in newborn
Respiratory distress in newborn
 
Respiratory distress syndrome^.^.pptx
Respiratory distress syndrome^.^.pptxRespiratory distress syndrome^.^.pptx
Respiratory distress syndrome^.^.pptx
 
Dr. Radhey Shyam (presentation)
Dr. Radhey Shyam (presentation)Dr. Radhey Shyam (presentation)
Dr. Radhey Shyam (presentation)
 
Continuous Positive Airway Pressure.pptx
Continuous Positive Airway Pressure.pptxContinuous Positive Airway Pressure.pptx
Continuous Positive Airway Pressure.pptx
 
Pediatric ARDS
Pediatric ARDSPediatric ARDS
Pediatric ARDS
 
Copd(留学生2009)
Copd(留学生2009)Copd(留学生2009)
Copd(留学生2009)
 
Respiratory Distress Syndrome by DR FAITHFUL DANIEL.pptx
Respiratory Distress Syndrome  by DR FAITHFUL DANIEL.pptxRespiratory Distress Syndrome  by DR FAITHFUL DANIEL.pptx
Respiratory Distress Syndrome by DR FAITHFUL DANIEL.pptx
 
Bronchectasis DISEASE MFM faculty 2017 .pdf
Bronchectasis DISEASE MFM faculty 2017 .pdfBronchectasis DISEASE MFM faculty 2017 .pdf
Bronchectasis DISEASE MFM faculty 2017 .pdf
 
Paediatric respiratory physiology
Paediatric  respiratory physiologyPaediatric  respiratory physiology
Paediatric respiratory physiology
 
Noisy breathing
Noisy breathingNoisy breathing
Noisy breathing
 

More from ShamiPokhrel2

17--nephropathy{17}.ppt
17--nephropathy{17}.ppt17--nephropathy{17}.ppt
17--nephropathy{17}.ppt
ShamiPokhrel2
 
RENAL TUBULAR ACIDOSIS.pptx
RENAL TUBULAR ACIDOSIS.pptxRENAL TUBULAR ACIDOSIS.pptx
RENAL TUBULAR ACIDOSIS.pptx
ShamiPokhrel2
 
14_-Mech_Vent-Troubleshootings_and_weaning(1).pptx
14_-Mech_Vent-Troubleshootings_and_weaning(1).pptx14_-Mech_Vent-Troubleshootings_and_weaning(1).pptx
14_-Mech_Vent-Troubleshootings_and_weaning(1).pptx
ShamiPokhrel2
 
18-Routine_care_in_PICU(1).pptx
18-Routine_care_in_PICU(1).pptx18-Routine_care_in_PICU(1).pptx
18-Routine_care_in_PICU(1).pptx
ShamiPokhrel2
 
20-COVID_19_and_MIS-C(1).pptx
20-COVID_19_and_MIS-C(1).pptx20-COVID_19_and_MIS-C(1).pptx
20-COVID_19_and_MIS-C(1).pptx
ShamiPokhrel2
 
4-Breathing_difficulties(1).pptx
4-Breathing_difficulties(1).pptx4-Breathing_difficulties(1).pptx
4-Breathing_difficulties(1).pptx
ShamiPokhrel2
 
13-Monitoring_in_PICU(1).pptx
13-Monitoring_in_PICU(1).pptx13-Monitoring_in_PICU(1).pptx
13-Monitoring_in_PICU(1).pptx
ShamiPokhrel2
 
10-Shock(1).pptx
10-Shock(1).pptx10-Shock(1).pptx
10-Shock(1).pptx
ShamiPokhrel2
 
7-Cardiac_arrest(1).pptx
7-Cardiac_arrest(1).pptx7-Cardiac_arrest(1).pptx
7-Cardiac_arrest(1).pptx
ShamiPokhrel2
 
Session 6. Stigma and Discrimination.ppt
Session 6. Stigma and Discrimination.pptSession 6. Stigma and Discrimination.ppt
Session 6. Stigma and Discrimination.ppt
ShamiPokhrel2
 
Session 2. Basics of HIV.ppt
Session 2. Basics of HIV.pptSession 2. Basics of HIV.ppt
Session 2. Basics of HIV.ppt
ShamiPokhrel2
 
phenylketonuria.ppt
phenylketonuria.pptphenylketonuria.ppt
phenylketonuria.ppt
ShamiPokhrel2
 
20-COVID_19_and_MIS-C(1).pptx
20-COVID_19_and_MIS-C(1).pptx20-COVID_19_and_MIS-C(1).pptx
20-COVID_19_and_MIS-C(1).pptx
ShamiPokhrel2
 
Croup syndrome.pptx
Croup syndrome.pptxCroup syndrome.pptx
Croup syndrome.pptx
ShamiPokhrel2
 
breastfeeding-121023054344-phpapp01.pptx
breastfeeding-121023054344-phpapp01.pptxbreastfeeding-121023054344-phpapp01.pptx
breastfeeding-121023054344-phpapp01.pptx
ShamiPokhrel2
 
7--HIE{7}.ppt
7--HIE{7}.ppt7--HIE{7}.ppt
7--HIE{7}.ppt
ShamiPokhrel2
 
3-nutrition{3}.ppt
3-nutrition{3}.ppt3-nutrition{3}.ppt
3-nutrition{3}.ppt
ShamiPokhrel2
 
Parental Role in Mother–Infant.pptx
Parental Role in Mother–Infant.pptxParental Role in Mother–Infant.pptx
Parental Role in Mother–Infant.pptx
ShamiPokhrel2
 
Models_of development.pptx
Models_of development.pptxModels_of development.pptx
Models_of development.pptx
ShamiPokhrel2
 
chronic kidney disease.pptx
chronic kidney disease.pptxchronic kidney disease.pptx
chronic kidney disease.pptx
ShamiPokhrel2
 

More from ShamiPokhrel2 (20)

17--nephropathy{17}.ppt
17--nephropathy{17}.ppt17--nephropathy{17}.ppt
17--nephropathy{17}.ppt
 
RENAL TUBULAR ACIDOSIS.pptx
RENAL TUBULAR ACIDOSIS.pptxRENAL TUBULAR ACIDOSIS.pptx
RENAL TUBULAR ACIDOSIS.pptx
 
14_-Mech_Vent-Troubleshootings_and_weaning(1).pptx
14_-Mech_Vent-Troubleshootings_and_weaning(1).pptx14_-Mech_Vent-Troubleshootings_and_weaning(1).pptx
14_-Mech_Vent-Troubleshootings_and_weaning(1).pptx
 
18-Routine_care_in_PICU(1).pptx
18-Routine_care_in_PICU(1).pptx18-Routine_care_in_PICU(1).pptx
18-Routine_care_in_PICU(1).pptx
 
20-COVID_19_and_MIS-C(1).pptx
20-COVID_19_and_MIS-C(1).pptx20-COVID_19_and_MIS-C(1).pptx
20-COVID_19_and_MIS-C(1).pptx
 
4-Breathing_difficulties(1).pptx
4-Breathing_difficulties(1).pptx4-Breathing_difficulties(1).pptx
4-Breathing_difficulties(1).pptx
 
13-Monitoring_in_PICU(1).pptx
13-Monitoring_in_PICU(1).pptx13-Monitoring_in_PICU(1).pptx
13-Monitoring_in_PICU(1).pptx
 
10-Shock(1).pptx
10-Shock(1).pptx10-Shock(1).pptx
10-Shock(1).pptx
 
7-Cardiac_arrest(1).pptx
7-Cardiac_arrest(1).pptx7-Cardiac_arrest(1).pptx
7-Cardiac_arrest(1).pptx
 
Session 6. Stigma and Discrimination.ppt
Session 6. Stigma and Discrimination.pptSession 6. Stigma and Discrimination.ppt
Session 6. Stigma and Discrimination.ppt
 
Session 2. Basics of HIV.ppt
Session 2. Basics of HIV.pptSession 2. Basics of HIV.ppt
Session 2. Basics of HIV.ppt
 
phenylketonuria.ppt
phenylketonuria.pptphenylketonuria.ppt
phenylketonuria.ppt
 
20-COVID_19_and_MIS-C(1).pptx
20-COVID_19_and_MIS-C(1).pptx20-COVID_19_and_MIS-C(1).pptx
20-COVID_19_and_MIS-C(1).pptx
 
Croup syndrome.pptx
Croup syndrome.pptxCroup syndrome.pptx
Croup syndrome.pptx
 
breastfeeding-121023054344-phpapp01.pptx
breastfeeding-121023054344-phpapp01.pptxbreastfeeding-121023054344-phpapp01.pptx
breastfeeding-121023054344-phpapp01.pptx
 
7--HIE{7}.ppt
7--HIE{7}.ppt7--HIE{7}.ppt
7--HIE{7}.ppt
 
3-nutrition{3}.ppt
3-nutrition{3}.ppt3-nutrition{3}.ppt
3-nutrition{3}.ppt
 
Parental Role in Mother–Infant.pptx
Parental Role in Mother–Infant.pptxParental Role in Mother–Infant.pptx
Parental Role in Mother–Infant.pptx
 
Models_of development.pptx
Models_of development.pptxModels_of development.pptx
Models_of development.pptx
 
chronic kidney disease.pptx
chronic kidney disease.pptxchronic kidney disease.pptx
chronic kidney disease.pptx
 

Recently uploaded

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 

Recently uploaded (20)

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 

6--NEONATOLOGY NRDS{6}.ppt

  • 1. 1 Neonatal Respiratory Distress Syndrome, NRDS (hyaline membrane disease, HMD)
  • 2. 2 Aims  To master the clinical manifestation and treatment principles  To understand the cause and Pathogenesis  To understand the differential diagnosis
  • 3. 3  Most common respiratory illness in NICU  Primarily characterized by respiratory distress  Occur virtually exclusively in premature neonate  The shorter the gestational age and the lower birth weight, the higher incidence, the less likely survival. High Spot
  • 4. 4 Most infants with the disease die from a complication , such as  intracranial hemorrhage  infection  air leak syndromes  bronchopulmonary dysplasia
  • 5. 5 Etiology  The main cause: Pulmonary Surfactant (PS) Deficiency
  • 6. 6  lowers the surface tension of the alveolar membrane.  maintains patent distal lung units at low volumes during expiration.  Increase in lung compliance. The Actions of pulmonary Surfactant: normal abnormal end expiratory
  • 7. 7 Phosphatidylcholine (75%) Phosphatidylglycerol (9%) Apoproteins (13%) Cholesterol Pulmonary Surfactant Constituent:
  • 8. 8 Pulmonary Surfactant  PS is produced by alveolar type Ⅱcells  At 24thweeks : begin to increase progressively with advancing gestational age  At 34th-36thweeks : large increase
  • 9. 9 The other factors  Genetic factors: white race, history of RDS in sibling, male sex. severe RDS---can not be cured----die  Hormones factors (adrenergic and steroid hormones can promote PS production and release ) elective cesarean section
  • 10. 10  Without surfactant the alveoli collapse at the end of expiration.  Pulmonary hypertension So, absence of surfactant cause hypoxia, acidosis, blood vessel contract , capillary vessel and alveolus osmosis increase, blood plasma leak, transparent membrane come into being, dyspnea, RDS Pathogenesis
  • 11. 11 absence of surfactant hypoxia, acidosis blood vessel contract capillary vessel and alveolus osmosis increase blood plasma leak transparent membrane come into being dyspnea. So, absence of surfactant cause NRDS
  • 12. 12  This in turn leads to respiratory failure .  In older infants surfactant deficiency can arise when they develop asphyxia 、 shock and acidosis.
  • 13. 13 Pathology  Generalized capillary leak and mucosal necrosis leads to the small air filled terminal airways.  The respiratory bronchioles and alveolar ducts, being surrounded by collapsed alveoli filled with debris in a near uniform distribution, and this leads to the classic "ground glass" appearance on the chest X-ray.
  • 14. 14  The NRDS affects the lung which is not mature at delivery.  Signs of respiratory distress appear in 2-6hr after birth.  Many of the patients appear signs within minutes of birth---shallow respirations are more than 60/min . Sign
  • 15. 15  Infants have physical findings of prematurity and present with inspiratory supraclavicular , suprasternal and intercostals retractions (three depression signs)
  • 16. 16 Clinical Manifestations  Tachypnea ( increasingly ) supraclavicular  Three depression suprasternal signs intercostals  Expiratory grunting (groan)  Cyanosis  Nasal flaring  Apneic episode
  • 17. 17  progressing to a paradoxical seesaw respiratory pattern in which the chest sinks is on inspiration as the abdomen balloons upward.  Expiratory grunting, tachypnea, flaring of the Nasal ala and requirement for oxygen completes the clinical picture.
  • 18. 18  As the infant’s energy reserves become depleted, there may be cessation of grunting.
  • 19. 19  Hypoperfusion and poor capillary filling may progress to hypotension and shock unless intervention is aggressive.  In most cases, the signs and symptoms may reach a peak within 3 days, followed by gradual resolution over the next 5-7days.
  • 20. 20  If the condition is inadequately treated, blood pressure and body temperature may fall.  Death is rare on the first day, usually occurs between days 2-7.
  • 21. 21 Complications Complications of NRDS include  infections (Sepsis)  intracranial hemorrhage  hyperbilirubinemia
  • 22. 22 Complications  PDA  Cardiac failure caused by a left-to- right shunt through a patent ductus arteriosus.  Pneumothorax  Chronic lung disease
  • 23. 23 Laboratory examination 1. Chest X-ray :  changes usually appear shortly after birth, but can be delayed for 12-24 hours. The typical pattern at 6-12 hour.  Ground glass appearance  Air bronchograms  White lung
  • 27. 27  2. Gastric aspirate shake (Foam test): Put 1ml gastric fluid and 1ml 95% alcohol into a tube, shake 15 seconds and keep still 15 minutes. If there is foam around the wall of the tube, it is positive. If not--negative.
  • 28. 28  3. Test of PS: Test amniotic fluid or tracheal fluid for lecithin / sphingomyelin. L/S ≥2 denotes mature lung, L/S <1.5 denotes immature lung, between 1.5 and 2 denotes doubtful.
  • 29. 29 Acid base In NRDS  pH  PaCO2  PaO2  HCO3 -  BE deficit
  • 30. 30 Diagnosis Process 1. History of premature 2. Clinical signs: Respiratory distress 3. X-ray : ground glass , Air bronchograms 4. Gastric aspirate shake: Negative 5. Blood gas and acid-base values: hypoxemia, hypercarbia and metabolic acidosis.
  • 31. 31 Differential Diagnosis of NRDS 1. GBS Infection pneumonia (Congenital pneumonia) – Pneumonia causes by group B streptococcus (GBS). Same signs of NRDS . – The chest X-ray may be identical in both diseases. The onset and the manifestations of respiratory distress are often indistinguishable. Apnea in the first few hours is more likely in GBS pneumonia. – Bacterial culture
  • 32. 32  Sepsis risk factors – Maternal fever, cough – Leukocytosis or leukopenia with neutropenia strongly suggests the presence of GBS infection. – Sometimes GBS can be found in gastric fluid.
  • 33. 33 2.Wet Lung Usually lung fluid is cleared from the interstitial space veins and lymphatics within 30 minutes after birth. Chest X-ray, usually has non-homogeneous densities, may have interlobar effusion . Clinical manifestations appear within several hours after birth, but are milder than HMD.
  • 34. 34 Lung fluid air First breath Second btreath 30min later Lung fluid clear away
  • 35. 35 3.Meconium aspiration  Common in full term infant or postterm infant  Gasping cause is the aspiration  Chemical diffuse pneumonitis  Chest X-ray, patchy areas of decreased aeration alternating with hyperventilation areas  Treatment mainly supportive
  • 36. 36 Treatment Principle  Surfactant …1990s – Prevention (100mg/Kg) – Rescue (200mg/Kg)  Supportive – Thermal – Fluid and nutrition – oxygen  Mechanical ventilation
  • 37. 37 Therapy 1. General Comments Therapy of hyaline membrane disease (HMD) is complex. Major responsibility befalls nurses. Blood gases and pH should be check according to necessary.
  • 38. 38 2.Surfactant Replacement Endotracheal instillation of surfactant replacement has dramatically improved survival and reduced the incidence of pulmonary air leaks. 100-200mg/kg drop in bronchi of both sides 2- 4 times. Curosurf (irrigating solution of piggy lung) Calsurf (irrigating solution of calf lung)
  • 39. 39 3. Other treatment 1) Respiratory Support a. Nasal oxygen catheter (Flow: 0.5-1L/min) Warm humidified oxygen should be provided to maintain :  PaO2 between 50 and 70 mmHg  pH above 7.25  PaCO2 between 45 and 50 mmHg.
  • 40. 40  b. CPAP(Continuos Positive Airway Pressure ): PEEP (positive end-expiratory pressure) : 4-10cm H2O. rhinobyon Air and o2mixer 4-10cmH2O
  • 41. 41
  • 42. 42 b. Mechanical ventilation : After CPAP (FiO2>60%), if PaO2<6.7Kpa (50mmHg) or PaCO2>7.9Kpa (60mmHg), ventilation should be used.  SIPPV (Synchronized Intermittent Positive Pressure Ventilation )  SIMV (Synchronized Intermittent Mandatory Ventilation )
  • 43. 43 2) Acid-base Balance – A metabolic acidosis can be prevented by adding a small quantity of sodium bicarbonate. – Formula  5% NaHCO3 3- 5ml/kg, one time, IV  5%NaHCO3 (mmol) = -BE ×0.3× kg  5%NaHCO3 (ml) = -BE × 0.5 × kg
  • 44. 44 3) Keep Body Temperature Maintenance of a neutral thermal environment ( skin temperature between 36.2-36.8℃) is of crucial importance.
  • 45. 45 4) Nutrition – During the first 24 to 48 hours, caloric needs are partially met by continuous intravenous infusion. volumes are 60-80 ml/kg/d. – Ensure that the blood sugar is maintained within a normal range(>2.5mmol/L). – If bowel sounds are audible and meconium has been passed, the milk should be fed.
  • 46. 46 5) Antibiotic can be used to prevent infection of lung.
  • 47. 47 Preventive measures 1. Prevent Premature Deliveries. Including :  avoidance of unnecessary or pool timed cesarean section  appropriate management of high-risk pregnancy and labor  prediction possible in uterus acceleration of pulmonary immaturity.
  • 48. 48 2. Administration of Corticosteroids There is good evidence that the administration of corticosteroids to mothers who are in premature labor to diminish the incidence of NRDS. Their effect is maximal at gestational ages between 28 and 32 weeks. Steroids should be administered between 24 hours and 7days before delivery.